Neuropace Inc (NPCE) — Capital Reinvestment Ratio

Latest as of December 2025: 0.19x

Neuropace Inc (NPCE) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow ($506.00K) in capital expenditures ($97.00K). See Neuropace Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.19x

Capex / Operating Cash Flow

Operating Cash Flow

$506.00K

USD

Capital Expenditures

$97.00K

USD

Data as of

Dec 2025

Most recent filing

Annual Capital Reinvestment Ratio for Neuropace Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Neuropace Inc from None to None. For live market cap and broader valuation context, see market value of Neuropace Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow